| Aktie | Ticker | 2026/Q1 | 2025/Q4 | ||||
|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 176.916.075 $ | +308.870 $ | -1,9 % | 176.607.205 $ | +176.607.205 $ | |||
| KESTRA MEDICAL TECHNOLOGIES, LTD. | KMTS | 53.715.177 $ | -13.648.434 $ | -20,3 % | 67.363.611 $ | +67.363.611 $ | |
| Mineralys Therapeutics, Inc. | MLYS | 43.125.032 $ | -14.645.636 $ | -25,4 % | 57.770.668 $ | +57.770.668 $ | |
| Evommune, Inc. | EVMN | 43.620.352 $ | +11.137.515 $ | +34,3 % | 32.482.837 $ | +32.482.837 $ | |
| Agomab Therapeutics NV | AGMB | 16.140.984 $ | +16.140.984 $ | ||||
| Abivax S.A. | ABVX | 8.699.219 $ | -1.836.328 $ | -17,4 % | 10.535.547 $ | +10.535.547 $ | |
| Inventiva S.A. | IVA | 10.090.905 $ | +1.636.363 $ | +19,4 % | 8.454.542 $ | +8.454.542 $ | |
| Nyxoah SA | NYXH | 1.524.406 $ | +1.524.406 $ | ||||
| 176.916.075 $ | +308.870 $ | -1,9 % | 176.607.205 $ | +176.607.205 $ | |||